SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Bio-Tech (India) informs about outcome of board meeting

25 Jul 2025 Evaluate
Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed that the Board of Directors of the Company, in their meeting held on today Friday 25th July 2025 at the Registered Office of the Company and transacted the following major businesses: Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2025. The board meeting commented at 03:10 pm and concluded at 03:40 pm.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh BioTech Share Price

0.61 0.00 (0.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Venkys India 1630.95
Mangalam Global Ent 14.24
Kaveri Seed 989.10
Regaal Resources 95.67
Simran Farms 169.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×